-
Mashup Score: 0
BACKGROUND: Electronic visits (e-visits), defined as structured asynchronous electronic messages between patients and clinicians requiring clinical decision-making, are being increasingly used to enhance access to outpatient health care services, but the primary care physicians who typically manage them face work overflow. Pharmacists have been proposed to manage e-visits that lead to prescription requests, but scant evidence exists about the effectiveness of this approach. OBJECTIVE: To compare pharmacist management of structured asynchronous e-visit requests for COVID-19 medication with physician management regarding quality of care, timeliness, and patient care experience. METHODS: This cluster-randomized clinical trial included adults from 17 medical facilities of Kaiser Permanente Northern California who made e-visits requesting COVID-19 medication (nirmatrelvir-ritonavir) from October 9 to December 11, 2023. In the Pharmacist Care group, a regional team of pharmacists managed e-v
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
BACKGROUND: The advent of next-generation imaging will likely reduce nonmetastatic prostate cancer (PC) prevalence and increase identification of metastatic prostate cancer cases, resulting in two predominant advanced stages in the metastatic setting. There is a need to characterize changes in health care resource utilization (HRU) and costs when metastatic castration-sensitive PC (mCSPC) progresses to metastatic castration-resistant PC (mCRPC) to identify value drivers from current and new treatments. OBJECTIVE: To describe treatment patterns, HRU, and total health care costs among patients with mCSPC, before and after progression to mCRPC. METHODS: Clinical data from the Flatiron Metastatic PC Core Registry (January 1, 2013, to December 1, 2021) and linked claims from Komodo Health (January 1, 2014, to December 1, 2021) were used to identify patients with progression from mCSPC to mCRPC (date of progression was the index date) and subsequently initiated first-line mCRPC therapy on/af
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
Following disease progression from stage IV prostate cancer to stage IV castration-resistant #prostatecancer, total #healthcare costs were 1.5 to 2X higher. Gain a better understanding of the large cost burden of prostate cancer as it worsens in #JMCP: https://t.co/JuYlwEOkMh https://t.co/iG1JTTIIWi
-
-
Mashup Score: 1A primer on quality measurement and reporting in pharmacy benefit plans | Journal of Managed Care & Specialty Pharmacy - 10 month(s) ago
Pharmacy benefit plans in the United States are evaluated on quality measures and other requirements of the government and accrediting organizations. This primer describes the roles of key organizations involved in measuring and reporting quality in pharmacy benefit plans and explains the methods that pharmacy benefit plans use to promote quality of medication use.
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
To improve the quality of pharmacy plans, pharmacy-benefit plans can implement a variety of interventions, including prescriber & pharmacy-directed activities, & medication therapy management programs. Learn more in the latest #AMCPprimer: https://t.co/UYqP9u5sKB #jmcp https://t.co/1i0zbWxEOD
-
-
Mashup Score: 1A primer on quality measurement and reporting in pharmacy benefit plans | Journal of Managed Care & Specialty Pharmacy - 10 month(s) ago
Pharmacy benefit plans in the United States are evaluated on quality measures and other requirements of the government and accrediting organizations. This primer describes the roles of key organizations involved in measuring and reporting quality in pharmacy benefit plans and explains the methods that pharmacy benefit plans use to promote quality of medication use.
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
To improve the quality of pharmacy plans, pharmacy-benefit plans can implement a variety of interventions, including prescriber & pharmacy-directed activities, & medication therapy management programs. Learn more in the latest #AMCPprimer: https://t.co/UYqP9u5sKB #jmcp https://t.co/1i0zbWxEOD
-
-
Mashup Score: 0Stakeholder views on requiring diagnosis or clinical indication on e-prescriptions | Journal of Managed Care & Specialty Pharmacy - 10 month(s) ago
BACKGROUND: Medication safety organizations have been recommending the inclusion of diagnosis or clinical indication on prescription orders for decades. However, this information is typically not provided by prescribers and shared with pharmacists, despite the availability of data fields in the most commonly used standard for electronic prescriptions. OBJECTIVE: To elucidate the views of selected industry stakeholders relative to perceived barriers to including diagnosis or indication on all electronic prescriptions. METHODS: Semistructured concept elicitation interviews identified key issues. Survey items were refined iteratively by the research team. The final instrument consisted of 34 questions intended to elicit the importance and relative priority of perceived barriers and potential solutions. A link to the Internet survey was emailed to members of the National Council for Prescription Drug Programs in February 2023, with biweekly follow-up reminders. RESULTS: A total of 139 surv
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
Should documenting a diagnosis code or indication on an e-prescription be required? Data from a recent survey of key industry stakeholders suggests near unanimous agreement that this could improve patient health & safety outcomes. Read more in #JMCP https://t.co/vw2Hu48BMm https://t.co/dXkhdUHTcq
-
-
Mashup Score: 0AMCP Format for Formulary Submissions 5.0 - 10 month(s) ago
VIEW ALL METRICS Select the citation format you wish to export for this article or chapter. Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled. Can’t sign in? Forgot your username? Can’t sign in? Forgot your password?
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
Newly updated: Version 5.0 of the AMCP Format for Formulary Submissions (AMCP Format.) https://t.co/PFGRiyie8j #AMCPFormat #MCPs #JMCP #managedcare #pharmacy https://t.co/BeBpUGNQmc
-
-
Mashup Score: 1Themed issue on drug pricing policy and the Inflation Reduction Act - 11 month(s) ago
This themed issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) features articles exploring drug pricing policy, with a special focus on implementation of the Inflation Reduction Act drug pricing provisions. The Inflation Reduction Act of 2022 authorizes the Centers for Medicare & Medicaid Services (CMS) to negotiate the prices of top-selling Medicare Part B and D drugs with pharmaceutical manufacturers. How CMS implements this program has important implications for managed care pharmacy.
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
#JMCP partnered with the @PhRMA Foundation to provide CMS with the knowledge and expertise of the research community as it enacts the #InflationReductionAct to ensure better health outcomes for all. https://t.co/AtnZC3TVmF #managedcare #pharmacy #IRA #Medicare https://t.co/RrYZQzbXAT
-
-
Mashup Score: 0AMCP Format for Formulary Submissions 5.0 - 12 month(s) ago
VIEW ALL METRICS Select the citation format you wish to export for this article or chapter. Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled. Can’t sign in? Forgot your username? Can’t sign in? Forgot your password?
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
Newly updated: Version 5.0 of the AMCP Format for Formulary Submissions (AMCP Format.) https://t.co/PFGRiyie8j #AMCPFormat #MCPs #JMCP #managedcare #pharmacy https://t.co/BeBpUGNQmc
-
-
Mashup Score: 4A primer on formulary structures and strategies - 12 month(s) ago
Formularies are a tool for managing costs, optimizing patient access, and improving overall health outcomes. The general goal of formularies is to provide access to appropriate therapy while promoting effective resource utilization, which allows the managed care pharmacy organization to operate sustainably. Traditional formulary strategies have included open and closed formularies as well as tiered formularies. However, other formulary structures have emerged in support of the focus on product value. The formulary development process is primarily driven by the pharmacy and therapeutics (P&T) committee and value committee within an organization. Key considerations such as member population, regional differences, regulatory/compliance implications, and benefit design strategies may influence payers to create a customized formulary to provide additional value to their members while managing costs. With the rise of high-cost and specialty products, formularies continue to serve as an impor
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
RT @DrugChannels: Helpful and neutral "#PBM formulary 101" article via @amcporg Good glossary! ==> https://t.co/h7Lo4wvSJo https://t.co/m…
-
-
Mashup Score: 0A summit on amplifying voices of patients, caregivers, and people with disabilities in Inflation Reduction Act drug price negotiations - 12 month(s) ago
On September 18, 2023, Cancer Support Community convened patient and caregiver advocates, health care providers, policy experts, and health care innovators and thought leaders for a roundtable discussion on the need to ensure that patients, people with disabilities, and caregivers have a voice in defining “clinical benefit” for the purpose of Medicare Part D drug price negotiations and future health care policies that impact patients. The meeting featured presentations from Lara Strawbridge, Deputy Director for Policy at the Medicare Drug Rebate and Negotiations Group in the Center for Medicare, regulatory expert, Dr Monique Nolan, Counsel at Arnold and Porter, LLP, and 3 panel discussions: IRA Implementation—What Matters to Patients, a discussion of policies expected to impact patients and caregivers who are likely to rely heavily on high-cost drugs or biologics to treat cancer or other chronic illnesses, as well as the future development of novel therapies; The Science of Measuring P
Source: www.jmcp.orgCategories: General Medicine News, PayerTweet-
As CMS begins to negotiate Medicare drug prices under the Inflation Reduction Act, researchers provide a framework of patient engagement to make sure patients are heard. Read the new #JMCP: https://t.co/7m1gSGe6QG #managedcare #pharmacy #IRA #Medicare #drugprices https://t.co/F1q6d4QL7I
-
Check out the latest issue of #JMCP to explore pharmacist vs. physician management of COVID-19 medication requests through e-visits. https://t.co/KRaA05rMqQ #JMCP #PharmacyCare #Telehealth #COVID19 #HealthCareInnovation https://t.co/0VRWEPIKfj